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PAPER
Prevalence of adults with brain arteriovenous
malformations: a community based study in Scotland
using capture-recapture analysis
R Al-Shahi, J S Y Fang, S C Lewis, C P Warlow
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Objective: To conduct a population based study of brain arteriovenous malformation (AVM)
prevalence.
Methods: Multiple, overlapping sources of case ascertainment were used to establish the point preva-
lence of brain AVMs in the adult population of the Lothian health board of Scotland. Patients were
sought retrospectively from all local general (family) practitioners, neurologists, neurosurgeons, stroke
physicians, the specialist AVM clinic at the regional neuroscience centre, and routine coding of hospi-
tal discharge data. Case notes, brain imaging, and pathology reports were reviewed to validate each
patient’s diagnosis and to ensure that each was alive, over the age of 16 years, and resident in the
geographical area of the study on the prevalence date of 30 June 1998.
Results: Of 148 potentially eligible people, 93 adults met the inclusion criteria. There were 40 women
and 53 men. Men were significantly younger than women on the prevalence date (median age 39
years v 51 years, p = 0.003). Of those included, 25 (27%) had radiological evidence of prior thera-
peutic obliteration of their brain AVM and 9 (10%) had coexisting aneurysms. The minimum crude
brain AVM prevalence was 15 per 100 000 adults and capture-recapture analysis gave an ascertain-
ment adjusted prevalence of 18 (95% confidence interval 16 to 24) per 100 000 adults.
Conclusions: The minimum estimate of brain AVM prevalence helps to assess its burden and
comparative epidemiology and stresses the importance of brain AVMs as a cause of long term disabil-
ity in adults.
Brain arteriovenous malformations (AVMs) account forapproximately one third of primary intracerebral haem-orrhage in young adults.1 In population based studies,
half of the adults with a first in a lifetime diagnosis of a brain
AVM present with intracranial haemorrhage.2 The risk of
death is greatest in the month following a first ever
haemorrhage, with a 30 day case fatality of about 18%.3 This
relatively low early case fatality and a subsequent annual case
fatality of about 1% is likely to leave a sizeable prevalent bur-
den of adults with long term disability who are potentially
exposed to the risks of recurrent haemorrhage or epilepsy.
Hospital based post mortem series have reported brain
AVM prevalence of up to about 600 per 100 000 but these
estimates are likely to have been considerably biased by the
method of cohort selection and the thoroughness of lesion
ascertainment.4–6 A community based study found the point
prevalence of the whole spectrum of intracranial vascular
malformation (IVMs) to be 19 (95% confidence interval (CI)
10 to 27) per 100 000 on 1 January 1990,7 from which an
upper limit for brain AVM prevalence of about 10 per 100 000
has been inferred.8 As yet there have been no population
based studies specifically investigating brain AVM
prevalence.1 8
The size of the study population and the methods of case
ascertainment affect prevalence estimates. Although larger
studies produce more precise estimates they are likely to miss
cases, whereas thorough ascertainment is more feasible in
smaller studies, which inevitably produce less precise
estimates. While common diseases such as stroke are amena-
ble to extensive surveys of population samples for the
disease,9 rarer disorders such as brain AVMs require targeted
surveillance of the parts of the health care system actively
involved in their management or passive inspection of
secondary data sources.
Therefore, we sought to estimate the prevalence of brain
AVMs in a sizeable adult population of a geographically and
demographically well defined community in Scotland, by
using active surveillance of clinicians involved in the care of
such people, as well as passive case ascertainment from
routinely collected data.
METHODS
Inclusion criteria
We included adults who were aged 16 years or over and per-
manently resident in the Lothian health board area of
Scotland on 30 June 1998 and in whom a brain AVM had
been diagnosed before this prevalence date. We defined a
brain AVM as an anastomosis of non-nutritive blood vessels
in the brain parenchyma, in which arteriovenous shunting
occurred in a central nidus (the tangle of vessels in which
usually multiple arteries and veins converge) or in a single
fistula between one feeding artery and one draining vein.
Diagnoses were deemed to be definite if there had been
unequivocal pathological examination or evidence of a
characteristic serpiginous cluster of calcified or enhancing
vessels on computed tomography, flow voids on magnetic
resonance imaging, or arteriovenous shunting on catheter
angiography.
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Exclusion criteria
We excluded people who did not fully meet the inclusion cri-
teria above and those with pure vein of Galen malformations,
dural AVMs, or any other type of IVM occasionally confused
with a brain AVM.10
Study setting
The Lothian health board covers 1813 km2 in southeast Scot-
land, ranging from the Pentland Hills to the shores of the Firth
of Forth and the North Sea, including the city of Edinburgh,
the capital and administrative centre of Scotland. The Lothian
health board is geographically defined by postcodes, enabling
clear criteria for residency within the community. Although
the most recent decennial census in Scotland was conducted
in 2001, the results are not yet available. Between censuses the
General Register Office for Scotland (<www.gro-
scotland.gov.uk>) estimates the size and age structure of the
Scottish population annually from registration of births and
deaths, as well as immigration and emigration data. The esti-
mated population of the Lothian health board on 30 June 1998
was 773 700, of whom 628 788 were > 16 years of age. The
stability of the whole population is reflected by a flux of only
0.2% over the year leading up to 30 June 1998, mostly attrib-
utable to 8892 births, 8157 deaths, and 665 estimated net
civilian migrations.4
The study was based at the regional neuroscience centre at
one hospital in Edinburgh, which serves the population of the
Lothian health board (and others) and provides the only spe-
cialist brain AVM clinic for the southeast of Scotland. Few
residents receive health care outside Scotland except on a
quaternary referral basis and there is little cross boundary
flow of the population for health care, which minimises miss-
ing diagnoses made outside Scotland. Almost every patient is
registered with a general (family) practitioner (GP). Virtually
all health care is accessed through the NHS and patients with
a diagnosis made in private practice are usually referred to the
NHS specialist brain AVM clinic. Apart from the usual
facilities for rehabilitation, there are no particular services that
would lead to the Lothian health board harbouring an excess
of disabled people.
The Information and Statistics Division (ISD) in Scotland
(<www.show.scot.nhs.uk/isd>) has centrally registered
every person discharged from an NHS hospital since 1980,
collated the General Register Office’s death certificate records,
and coded main and subsidiary diagnoses according to the 9th
and 10th revisions of the International classification of diseases
(ICD). These databases are available for use in research stud-
ies with ethics committee approval. Several mechanisms for
ensuring data quality are in place at ISD, including validation,
accreditation, quality assurance and monitoring, and national
coding advice and training programmes.11
Study design
We usedmultiple overlapping sources of case ascertainment to
identify adults meeting the inclusion criteria.
Collaborative neuroscience network
We approached all consultant neurologists, neurosurgeons, and
stroke physicians covering the study area, who were also part of
a collaborative network participating in a larger, nationwide
incidence study of adults with IVMs, to obtain lists of their
patients meeting our inclusion criteria. We also searched the
diaries from 1995 until 2000 of the specialist brain AVM clinic
operating at the regional neuroscience centre.
General (family) practitioners
We wrote to all 557 GPs at the 101 general practices in the
study area in 1999, requesting details of adults registered at
the practices who met our inclusion criteria. We presupposed
that GPs would find such people memorable, as each GP was
unlikely to look after more than one person with a brain AVM.
We were unable to search GPs’ patient databases because of
the inadequate coding of brain AVMs in their “Read” coding
system and because of changes in data protection legislation
in the United Kingdom and confidentiality guidance at the
time of this study.12
Routine coding of hospital discharge data
In early 2000, colleagues at ISD searched the national
database of hospital admissions and discharges (Scottish
Morbidity Records). They identified every adult who was alive
on the prevalence date and who had been discharged from a
Scottish hospital to an address in the Lothian health board at
any time with an ICD code for a brain AVM (ICD-10 codes
I60.8 and Q28.2; ICD-9 codes 430 and 747.8).
Data collection and validation
All available case notes, and brain imaging and pathology
reports were reviewed to validate each person’s brain AVM
diagnosis and to ensure that they were alive, over the age of 16
years, and resident in the geographical area of the study on the
prevalence date of 30 June 1998. Brain imaging, pathology
reports, or both were available in every case. Residence was
determined by comparing an adult’s home postcode on the
prevalence date with a database of all the postcodes defining
the Lothian health board. We had no difficulty in matching
duplicate notifications of adults between the sources by using
first name, surname, and date of birth, in the absence of any
other unique identifier.
Statistical analysis
We calculated crude prevalence as the proportion of the adult
(aged > 16 years) mid-year population estimate for the
Lothian health board that was known to fulfil our inclusion
criteria. Age standardised prevalence estimates were directly
age adjusted to the last census in the United Kingdom in 1991
(<http://www.census.ac.uk>) and the last census in the
United States in 2000 (<http://factfinder.census.gov>). We
based 95% CIs around prevalence estimates on the Poisson
distribution and calculated them with confidence interval
analysis software.13 Tests for significance were performed in
SPSS version 10.0.5 (SPSS Inc, Chicago, Illinois, USA). SAS
version 8 (SAS Institute, Cary, North Carolina, USA) was used
for capture-recapture analysis.
Ethical approval
This study was approved by the Multicentre Research Ethics
Committee for Scotland (MREC/98/0/48) and the Lothian
Local Research Ethics Committee.
Figure 1 Flow diagram of people notified to the study. AVM,
arteriovenous malformation.
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RESULTS
Recruitment
In total, 148 people were identified by the three sources of case
ascertainment as potentially meeting the study inclusion cri-
teria. Of these people, medical records were missing in four
and 51 were excluded (mainly because they were resident
outside the Lothian health board), leaving 93 adults included
in the study (fig 1).
Baseline characteristics
Of those included, 53 were men and 40 were women, and men
were significantly younger on the prevalence date than
women (median age 39 years v 51 years, p = 0.003; table 1).
The majority (72; 77%) had been investigated with catheter
angiography, usually in combination with axial brain imaging
(fig 2). Nine adults (10%) had coexisting aneurysms. Fifty
eight (62%) of 93 brain AVMs were located in so called
eloquent areas (table 2), according to the Spetzler-Martin
grading scheme’s determination of eloquence (hypothalamus,
thalamus, brain stem, cerebellar peduncles, and sensorimotor,
language, and visual cortex).14 Every brain AVM was solitary
and did not occur in combination with any other IVM. There
was radiological evidence of therapeutic obliteration of the
AVM in 25 (27%) adults.
Prevalence
Ninety three adults had had a brain AVM diagnosed at some
time during their life and were living in the Lothian health
board on 30 June 1998, giving a crude prevalence of 14.8 (95%
CI 11.9 to 18.1) per 100 000 adults. Figure 3 shows age and sex
specific prevalences. Men were more prevalent in younger age
groups, explaining their lower median age at diagnosis,
although the 95% CIs of the sex specific prevalence estimates
overlapped in each mid-decade age band. Prevalences directly
age adjusted to the 1991 census population in the United
Kingdom and the 2000 census population in the United States
were 14.6 and 14.7 per 100 000 adults, respectively.
Adjustment for incomplete case ascertainment
Figure 4 shows the degree of overlap between the study’s three
major sources of case ascertainment. Routine coding of hospi-
tal discharge data was the most productive source, identifying
70 (75%) patients, followed by hospital consultants and AVM
clinic diaries (48; 52%) and GPs (36; 39%). There was a
sizeable overlap between sources, with 47 (51%) adults identi-
fied by at least two sources. We have used capture-recapture
analysis to estimate the number of people potentially missed,
based on the observed overlap between the three sources of
case ascertainment.15 We presupposed that the sources would
be dependent but to varying degrees and that there was most
likely to be dependence between hospital consultants/
specialist brain AVM clinic and routine coding because of the
derivation of the latter from the former.
There are eight possible log-linear models, each with a dif-
ferent configuration of dependencies between three sources of
ascertainment (table 3). The residual deviance is a measure of
the “goodness of fit” of each model compared with the model
in which all sources are assumed to be dependent; the better
the fit, the lower the residual deviance. The model we chose
had the lowest residual deviance and estimated that 20 (95%
CI 7 to 55) prevalent adults were missed by our study. The
coverage (or completeness) of our study—calculated from the
number of cases observed (93) as a proportion of the cases
Table 1 Baseline characteristics of 93 prevalent
adults with brain arteriovenous malformations (AVMs)
Characteristic Number
Prevalent adults 93
Men (%) 53 (57)
Median age on the prevalence date (25% and
75% quartiles) (years)
Men 39 (30–53)*
Women 51 (44–65)*
Coexisting aneurysms
Nidal 2 }9 (10%)Feeding artery 6
Remote 1
Radiological evidence of AVM obliteration
following treatment (%)
25 (27)
*p=0.003 (Mann-Whitney U test).
Figure 2 Venn diagram illustrating the radiological investigations
that led to a definite diagnosis of a brain AVM in the 93 prevalent
adults.
Table 2 Principal locations of the 93 brain AVMs,
their laterality, and their so called eloquence
(asterisked) according to the Spetzler-Martin grading
scheme16
Location
Side
Left Midline Right
Frontal 6* 1 6
Frontotemporal 0 0 2
Frontoparietal 3* 0 2*
Temporal 7 (4*) 0 9
Temporoparietal 4* 0 4
Parietal 10* 0 15*
Parieto-occipital 5 0 4
Occipital 4* 0 0
Thalamus 1* 0 2*
Medulla 0 1* 0
Cerebellum 2* 1 4*
Total (%) 42 (45%) 3 (3%) 48 (52%)
Figure 3 Age and sex specific crude point prevalences for adults
with brain arteriovenous malformations, with lower 95% confidence
intervals (CIs) and upper 95% CIs.
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expected on the basis of capture-recapture analysis (100 to
148)—was 63–93%. By including this estimate of 20 missed
cases, the ascertainment adjusted brain AVM prevalence was
18 (95% CI 16 to 24) per 100 000 adults.
DISCUSSION
In this first community based study of brain AVM prevalence,
we found a crude prevalence of 15 (95% CI 12 to 18) per
100 000 adults. The prevalence may be as high as 18 (95% CI
16 to 24) per 100 000 adults if capture-recapture analysis is
used to estimate the number of cases missed by our ascertain-
ment process. Therefore, using the 95% CI around this second
estimate, in the year 2000, we find that adults with a brain
AVM numbered between 650 and 1000 in Scotland, 7600 and
11 400 in the United Kingdom, and 35 400 and 53 000 in the
United States. Our study illustrates the burden on the public
health care system of a condition that has potential long term
risks of recurrent intracranial haemorrhage and epilepsy, as
well as other disability, and that attracts expensive interven-
tional treatments. These estimates have implications for the
planning, purchasing, and provision of health services for
people with a brain AVM.
The nature of brain AVMs
Brain AVMs themselves pose several challenges for epidemio-
logical studies. The people who have a diagnosis of brain AVM
are probably an inherently biased group, as the suspicion of an
underlying brain AVM and the use of investigations to identify
it depend on aspects of the patient and their presentation.
Younger people with recurrent intracranial haemorrhage,
recurrent or focal epilepsy, and atypical headache are more
likely to be investigated. Regional investigation practices
among neurologists, neurosurgeons, and neuroradiologists
would further influence these biases, as would the availability
of brain imaging and catheter angiography. Moreover, any
prevalence estimate would be affected by historical patterns of
investigation—the paucity of elderly people in our sample is
undoubtedly affected by the reliance on catheter angiography
for diagnosis before the 1970s.
These same factors influence the detection of asymptomatic
brain AVMs. The number of asymptomatic brain AVMs at any
one time remains in some senses imponderable because the
development of brain AVMs is likely to be dynamic—they are
not necessarily congenital.16 Although published studies of
asymptomatic volunteers undergoing magnetic resonance
imaging have not detected asymptomatic brain AVMs,17 18 a
“brain check up” system in Japan has found, using magnetic
resonance angiography, 3 (0.1%) of 3085 apparently healthy
people (mean age 55 (11) years, male to female ratio 2:1) to
harbour a brain AVM (Yukito Shinohara, Tokai University
School of Medicine, personal communication).
Methodological biases
This study is best regarded as providing a minimum estimate
of brain AVM prevalence. While complete ascertainment and
overlap between sources would be desirable, it is virtually
impossible in any study of a large population. Our estimate of
63–93% completeness (based on capture-recapture analysis)
appears reasonable. The extent of intersection of our sources
of ascertainment would have been affected by the number of
adults admitted to hospital and so included in routine coding,
the accuracy of hospital discharge data and ICD coding, the
thoroughness of GP, consultant, and AVM clinic records, and
the extent of clinicians’ memories. The absence of any other
feasible, local sources of case ascertainment make this study
difficult to improve upon. Perhaps a future cross sectional
analysis of our longitudinal inception cohort study of all inci-
dent IVMs in the adult population of Scotland would be more
precise and so have good statistical power to detect any future
change from our contemporary prevalence estimate.
Capture-recapture analysis
Capture-recapture methods were originally developed by
ecologists for censuses of wildlife. Animals are captured,
tagged, and released back into the wild, and the process
repeated. The total size of the animal population is estimated
from the proportion of animals that were tagged by the first
capture and “recaptured” by the second. The parallels with
epidemiological studies using several sources have resulted in
widespread, albeit controversial, use of the technique.15 19
Capture-recapture analysis has been particularly useful for
estimating the frequency of neurological conditions because it
minimises the cost of exhaustive methods of case ascertain-
ment and prevents underestimation of disease frequency.20 21
However, the results of capture-recapture analysis must be
interpreted and presented with caution22 because the assump-
tions inherent in the technique do not always hold in human
populations.19 20 23
The technique requires that the population size be constant
(that is, there are no changes due to birth, death, or
Figure 4 Venn diagram of overlap between the sources of case
ascertainment of the 93 prevalent adults.
Table 3 Eight log-linear models for three source capture-recapture analyses,
accompanied by the residual deviance and estimated number of missing cases (with
95% confidence interval (CI)) for each model
Model Residual deviance Cases missed (95% CI)
Independent 2.4 13 (7 to 23)
GP – hospital 1.0 15 (8 to 29)
Hospital – coding 2.4 14 (6 to 33)
GP – coding 2.4 13 (6 to 28)
GP – hospital, GP – coding 0.9 17 (7 to 39)
GP – hospital, hospital – coding* 0.7 20 (7 to 55)
Hospital – coding, GP – coding 2.3 15 (4 to 56)
Hospital – coding, GP – coding, GP – hospital 0 34 (7 to 172)
*The chosen model. –, source dependence; GP, general (family) practitioner.
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migration), that members of the population under study be
recognisable and equally “catchable”, and that the sources of
ascertainment be independent to enable the use of asymptotic
statistical theory. Although study of a fixed population is
impossible, stable populations—such as the Lothian health
board—are an adequate approximation. In the health care
setting, sources of ascertainment are usually dependent to
varying degrees; for example, inclusion in one source (hospi-
tal consultant and AVM clinic records) confers inclusion in
another source (routine coding of hospital discharge data).
Such positive dependency between two sources may underes-
timate the number of people missed. Certain aspects of people
may make them more likely to be ascertained by one source
than another (for example, people investigated as outpatients
who are not thought to require treatment are more likely to be
identified by GPs than by AVM clinic diaries). Such negative
dependency between sources may overestimate the number of
people missed. The assumption of equal “catchability” rarely
holds because severely affected people are more likely to be
captured.21 Therefore, the estimate of the total population of
adults with brain AVMs may be biased by assuming that the
missing cases resemble the ascertained ones.
While capture-recapture analysis is most straightforward
when two sources are used, the above complexities of human
populations have attracted methods that use more than two
sources and log-linear modelling of source dependencies.15 It is
generally held that three sources are ideal in epidemiological
studies. Clearly the number of missing people is sensitive to
the choice of model (table 3).We chose the most parsimonious
model that did not assume dependence between all three
sources but that modelled dependence between GPs and the
hospital source, as well as the dependence we had presup-
posed to exist between the hospital source and routine coding.
This latter dependence was expected in practice because rou-
tine coding is derived from records of hospital admissions. In
our chosen model, the other dependence (between GPs and
hospital based sources) is unsurprising, given the reliance on
hospital based investigations for brain AVM diagnosis.
A recent approach to address the influence of patient char-
acteristics that may influence the probability of capture by
different sources (for example, demographics and disease
severity) has been to stratify patients by these characteristics
or to use a multinomial logit model to identify and account for
them.21 24 This is an approach we would have used, were it not
for the unavailability of the complete medical record in every
case.
Conclusions
Our minimum prevalence estimates portray the impact of
brain AVMs on public health. The methods and analysis of
case ascertainment in this study form the basis for statistical
power calculations for other prevalence studies. There is also
growing interest in the incidence of brain AVMs and the
impact of diagnostic suspicion bias and brain imaging use on
detection rates.2 25 26 Such population based studies will also
further knowledge about the comparative epidemiology,
burden, and prognosis of brain AVMs.
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